Trinity Biotech Stock Forward View - Simple Regression
| TRIB Stock | USD 0.82 0.06 7.26% |
Trinity Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Trinity Biotech stock prices and determine the direction of Trinity Biotech plc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Trinity Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the relative strength index (RSI) of Trinity Biotech's share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Trinity Biotech, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.77) | EPS Estimate Next Quarter (0.51) | EPS Estimate Next Year (1.09) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.57) |
Using Trinity Biotech hype-based prediction, you can estimate the value of Trinity Biotech plc from the perspective of Trinity Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Trinity Biotech using Trinity Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Trinity using crowd psychology based on the activity and movement of Trinity Biotech's stock price.
Trinity Biotech Short Interest
A significant increase or decrease in Trinity Biotech's short interest from the previous month could be a good indicator of investor sentiment towards Trinity. Short interest can provide insight into the potential direction of Trinity Biotech stock and how bullish or bearish investors feel about the market overall.
200 Day MA 0.8609 | Short Percent 0.0067 | Short Ratio 0.61 | Shares Short Prior Month 408.2 K | 50 Day MA 1.0576 |
Trinity Relative Strength Index
The Simple Regression forecasted value of Trinity Biotech plc on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.88.Trinity Biotech plc Hype to Price Pattern
Investor biases related to Trinity Biotech's public news can be used to forecast risks associated with an investment in Trinity. The trend in average sentiment can be used to explain how an investor holding Trinity can time the market purely based on public headlines and social activities around Trinity Biotech plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Trinity Biotech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Trinity Biotech.
Trinity Biotech Implied Volatility | 4.6 |
Trinity Biotech's implied volatility exposes the market's sentiment of Trinity Biotech plc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trinity Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trinity Biotech stock will not fluctuate a lot when Trinity Biotech's options are near their expiration.
The Simple Regression forecasted value of Trinity Biotech plc on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.88. Trinity Biotech after-hype prediction price | USD 0.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Trinity Biotech to cross-verify your projections. Open Interest Against 2026-03-20 Trinity Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Trinity Biotech's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Trinity Biotech's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Trinity Biotech stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Trinity Biotech's open interest, investors have to compare it to Trinity Biotech's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Trinity Biotech is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Trinity. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Trinity Biotech Additional Predictive Modules
Most predictive techniques to examine Trinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Trinity using various technical indicators. When you analyze Trinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Trinity Biotech Simple Regression Price Forecast For the 1st of February
Given 90 days horizon, the Simple Regression forecasted value of Trinity Biotech plc on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.88.Please note that although there have been many attempts to predict Trinity Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Trinity Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Trinity Biotech Stock Forecast Pattern
| Backtest Trinity Biotech | Trinity Biotech Price Prediction | Buy or Sell Advice |
Trinity Biotech Forecasted Value
In the context of forecasting Trinity Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Trinity Biotech's downside and upside margins for the forecasting period are 0.01 and 9.07, respectively. We have considered Trinity Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Trinity Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Trinity Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.6462 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0948 |
| MAPE | Mean absolute percentage error | 0.1063 |
| SAE | Sum of the absolute errors | 5.8773 |
Predictive Modules for Trinity Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Trinity Biotech plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Trinity Biotech After-Hype Price Density Analysis
As far as predicting the price of Trinity Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Trinity Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Trinity Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Trinity Biotech Estimiated After-Hype Price Volatility
In the context of predicting Trinity Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Trinity Biotech's historical news coverage. Trinity Biotech's after-hype downside and upside margins for the prediction period are 0.04 and 9.09, respectively. We have considered Trinity Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Trinity Biotech is abnormally volatile at this time. Analysis and calculation of next after-hype price of Trinity Biotech plc is based on 3 months time horizon.
Trinity Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Trinity Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Trinity Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Trinity Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 8.27 | 0.00 | 0.00 | 12 Events / Month | 5 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.82 | 0.82 | 0.48 |
|
Trinity Biotech Hype Timeline
Trinity Biotech plc is at this time traded for 0.82. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Trinity is forecasted to increase in value after the next headline, with the price projected to jump to 0.82 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 0.48%, whereas the daily expected return is at this time at 0.01%. The volatility of related hype on Trinity Biotech is about 19232.56%, with the expected price after the next announcement by competition of 0.82. The company reported the previous year's revenue of 61.55 M. Net Loss for the year was (31.79 M) with profit before overhead, payroll, taxes, and interest of 21.44 M. Given the investment horizon of 90 days the next forecasted press release will be in about 12 days. Check out Historical Fundamental Analysis of Trinity Biotech to cross-verify your projections.Trinity Biotech Related Hype Analysis
Having access to credible news sources related to Trinity Biotech's direct competition is more important than ever and may enhance your ability to predict Trinity Biotech's future price movements. Getting to know how Trinity Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Trinity Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADVB | Advanced Biomed Common | 0.01 | 4 per month | 0.00 | (0.09) | 10.00 | (10.81) | 39.70 | |
| BGLC | BioNexus Gene Lab | 0.03 | 8 per month | 0.00 | (0.28) | 4.14 | (7.25) | 16.78 | |
| XAIR | Beyond Air | 0.01 | 9 per month | 6.24 | 0.01 | 14.46 | (10.16) | 163.02 | |
| MRKR | Marker Therapeutics | (0.05) | 10 per month | 5.11 | 0.13 | 12.79 | (8.63) | 28.69 | |
| CHEK | Check Cap | 0.01 | 8 per month | 6.07 | 0.12 | 17.16 | (10.37) | 198.26 | |
| GBS | GBS Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SINT | SINTX Technologies | 0.25 | 9 per month | 5.15 | 0 | 9.09 | (5.90) | 32.00 | |
| EVGN | Evogene | 0.01 | 7 per month | 0.00 | (0.09) | 3.77 | (5.22) | 21.65 | |
| SNSE | Sensei Biotherapeutics | 0.11 | 7 per month | 5.92 | 0.01 | 17.33 | (10.69) | 36.61 | |
| TNON | Tenon Medical | 0.05 | 7 per month | 0.00 | (0.15) | 5.61 | (4.04) | 16.03 |
Other Forecasting Options for Trinity Biotech
For every potential investor in Trinity, whether a beginner or expert, Trinity Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Trinity Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Trinity. Basic forecasting techniques help filter out the noise by identifying Trinity Biotech's price trends.Trinity Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trinity Biotech stock to make a market-neutral strategy. Peer analysis of Trinity Biotech could also be used in its relative valuation, which is a method of valuing Trinity Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Trinity Biotech Market Strength Events
Market strength indicators help investors to evaluate how Trinity Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trinity Biotech shares will generate the highest return on investment. By undertsting and applying Trinity Biotech stock market strength indicators, traders can identify Trinity Biotech plc entry and exit signals to maximize returns.
Trinity Biotech Risk Indicators
The analysis of Trinity Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Trinity Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting trinity stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.29 | |||
| Semi Deviation | 5.13 | |||
| Standard Deviation | 7.93 | |||
| Variance | 62.81 | |||
| Downside Variance | 38.52 | |||
| Semi Variance | 26.31 | |||
| Expected Short fall | (7.30) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Trinity Biotech
The number of cover stories for Trinity Biotech depends on current market conditions and Trinity Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Trinity Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Trinity Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Trinity Biotech Short Properties
Trinity Biotech's future price predictability will typically decrease when Trinity Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Trinity Biotech plc often depends not only on the future outlook of the potential Trinity Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Trinity Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18 M | |
| Cash And Short Term Investments | 5.2 M |
Check out Historical Fundamental Analysis of Trinity Biotech to cross-verify your projections. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Trinity Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.77) | Earnings Share (1.80) | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
Trinity Biotech plc's market price often diverges from its book value, the accounting figure shown on Trinity's balance sheet. Smart investors calculate Trinity Biotech's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Trinity Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.